Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Infectio
versión impresa ISSN 0123-9392
Resumen
BARBOZA, Joshuan J. et al. Kawasaki disease, Kawasaki-like disease, and MIS-C associated with COVID-19 in children: systematic review. Infect. [online]. 2022, vol.26, n.2, pp.137-144. Epub 12-Dic-2021. ISSN 0123-9392. https://doi.org/10.22354/in.v26i2.1012.
Objective:
To synthesize the epidemiological and clinical characteristics of COVID-19 children with MIS-C, KLD and EK.
Methods:
Databases and preprints were searched until May 31, 2021. Reports/case series that evaluated the clinical features of EK, KLD, or MIS-C in pediatric patients with COVID-19 were included.
Results:
Sixteen studies were included (six case reports and ten case series, 367 patients total, 58 patients with EK, 87 with KLD, and 290 patients with MIS-C); with ages ranging from 6 months to 10 years, and 62% were female. Positive COVID-19 was observed in 75.2%. Regarding EK, KLD and MIS-C, the reported clinical characteristics were compatible with the standardized diagnostic pictures in the context of COVID-19. The duration of hospitalization was 5 to 14 days for EK and 4.3 to 13 for MIS-C. Eleven patients with MIS-C (2.8%) needed ECMO. Eleven patients with MIS-C (2.8%) needed ECMO. Six patients with MIS-C were reported dead. Eight studies reported patients in the ICU.
Conclusions:
Children with COVID-19 develop EK or KLD, and can be complicated by MIS-C. Prevention, diagnosis, and treatment measures are needed.
Palabras clave : Kawasaki diseases; Multisystemic inflammatory syndrome; COVID-19.